Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Infusion Of Human Immune Globulin G (IgG), 10%, and Recombinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase 3 Extension Study In Patients With Primary Immunodeficiencies (PIs)
Melamed, Isaac Reuven, Wasserman, Richard L., Stein, Mark, Rubinstein, Arye, Puck, Jennifer M., Gupta, Sudhir, Engl, Werner, Leibl, Heinz, Yel, Leman, Schiff, Richard I.Volume:
133
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2013.12.645
Date:
February, 2014
File:
PDF, 41 KB
english, 2014